Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | THPO | P40225 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | MME | P08473 | 5/20 | 0.48 |
| ▸ | GNPAT | O15228 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.40 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2122264 | 1.00 | MAPT (0.64) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL79541 | 1.00 | MAPT (0.64) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Phosphine SCHEMBL27436960 | 0.98 | MAPT (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Hydrogen Sulfide SCHEMBL28866152 | 0.98 | MAPT (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Benzene SCHEMBL3450679 | 0.95 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Nitrogen SCHEMBL28192495 | 0.95 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL3503686 | 0.91 | MAPT (0.55) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL3503684 | 0.91 | MAPT (0.55) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL10346770 | 0.88 | KDM4E (0.52) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Biphenyl SCHEMBL28800728 | 0.86 | TGFBR1 (0.50) | MAPTKDM4ETHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7567 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-12534747-B2 | Microorganism producing L-amino acid and method of producing L-amino acid using the same | CJ CHEILJEDANG CORPORATION (KR) | 2026-01-27 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| WO-2025123045-A1 | PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-06-12 | — | — | WO | claimed |
| CN-120119253-A | High-stability titanium etching solution and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | WASHINGTON UNIVERSITY | 2025-05-29 | — | — | US | claimed |
| EP-3615069-B1 | N-ACETYLATED AND NON-ACETYLATED DIPEPTIDES CONTAINING ARGININE TO REDUCE THE VISCOSITY OF VISCOUS COMPOSITIONS OF THERAPEUTIC POLYPEPTIDES | AMGEN INC (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119915926-A | Application of serum N-acetylserine in preparation of type 2 diabetic nephropathy diagnosis and prognosis evaluation products | 河南省人民医院 | 2025-05-02 | — | — | CN | claimed |
| EP-3555615-B9 | MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES | METABOLON INC (US) | 2025-03-19 | — | — | EP | claimed |
| US-5472698-A | Mixture of (N-acetyl)-L-serine, N-acetylcysteine and alpha-lipoic acid which promotes ceramide production in skin cells | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1995-12-05 | — | — | US | claimed |
| EP-0458841-B1 | METHOD FOR THE USE AND SYNTHESIS OF PEPTIDES | CHIRON MIMOTOPES PTY LTD (AU) | 1995-06-14 | — | — | EP | claimed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | claimed |
| US-5008372-A | Reacting with anhydrous trifluoroacetic acid | CORNELL RESEARCH FOUNDATION, INC. (US) | 1991-04-16 | — | — | US | claimed |
| US-4910296-A | Polypeptide | MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1990-03-20 | — | — | US | claimed |
| EP-0142487-B1 | NOVEL ATRIAL PEPTIDES | WASHINGTON UNIVERSITY (US) | 1990-01-03 | — | — | EP | claimed |
| EP-0301873-A2 | 2'-deoxy-5-fluorouridine derivatives | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1989-02-01 | — | — | EP | claimed |
| US-4612365-A | Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments | MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN (DE) | 1986-09-16 | — | — | US | claimed |
| EP-0142487-A2 | Novel atrial peptides | WASHINGTON UNIVERSITY (US) | 1985-05-22 | — | — | EP | claimed |
| EP-0056594-B1 | THYMOSIN-ALPHA-1 FRAGMENTS AND PHARMACEUTICAL COMPOSITIONS WITH IMMUNOREGULATING ACTION CONTAINING THEM | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-09-12 | — | — | EP | claimed |